Eli Lilly & Company Foundation

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$21M
Portfolio companies 4
Rounds per year 0.08
Lead investments 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Non Profit
  • Biopharma
  • Life Science
  • Health Care

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Eli Lilly & Company Foundation:
Typical Co-investors
Eli Lilly & Company Foundation is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Eli Lilly & Company Foundation:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Batshit Crazy Ventures Boulder, Colorado, United States
BlueGem Capital Partners England, London, United Kingdom
ChemRar Ltd Khimki, Moscow Oblast, Russia
Cossette Canada, Quebec, Quebec
Cowtown Angels Fort Worth, Texas, United States
Crystal Internet Venture Funds Cleveland, Ohio, United States
CureDuchenne Ventures -
Fung Shing Investments -
Hongrui Touzi China, Jiading, Shanghai
Inner Mongolia Kenuohuagai Investment Management -
KNT-CT Holdings Japan, Tokyo
Link11 Frankfurt, Germany, Hessen
Panorama Point Partners Nebraska, Omaha, United States
Sesame Workshop New York, New York, United States
Soilbuild Group Holdings Central, Central Region, Singapore
Taixiang Investment Management China, Ningbo, Zhejiang
Yifeng Investment China, Shanghai
ZenPharma Limited -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Fountain Therapeutics

Biotechnology
Health Care
Therapeutics
$15M18 Nov 2021 San Francisco, California, United States

Amphista Therapeutics

Biopharma
Biotechnology
$53M17 Mar 2021 Scotland

Indianapolis Cultural Trail

Non Profit
$1M23 Feb 2021 Indianapolis, Indiana, United States
News
MiNA Therapeutics Receives $15M Equity Investment from Eli Lilly and Company

– MiNA Therapeutics Limited is a London, UK-based provider of small activating RNA therapeutics.
– Company received $15m equity investment from Eli Lilly and Company.
– The funds will be used to advance and expand its internal pipeline of saRNA therapeutics.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Eli Lilly & Company Foundation?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: